Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hasnain Khandwala

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Biochemistry|September 11, 2007
Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitusHui Wang, Qing H Meng, John R Gordon, et al.
Diabetes Research and Clinical Practice|August 26, 2019
Patient Reported Outcomes following initiation of Glucagon-like peptide-1 Receptor agonists in patients with type 2 Diabetes in a specialist endocrinology practice of the LMC diabetes registry: The PROGRESS-Diabetes studyRuth E Brown, Alexander Abitbol, Harpreet S Bajaj, et al.
Diabetes, Obesity & Metabolism|December 22, 2022
IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trialRonnie Aronson, Ruth E Brown, Lisa Chu, et al.
Diabetes Care|December 4, 2016
Lowest Glucose Variability and Hypoglycemia Are Observed With the Combination of a GLP-1 Receptor Agonist and Basal Insulin (VARIATION Study)Harpreet S Bajaj, Karri Venn, Chenglin Ye, et al.
Canadian Journal of Diabetes|May 29, 2018
Diabetes Canada Position Statement for People With Types 1 and 2 Diabetes Who Fast During RamadanHarpreet Singh Bajaj, Tyceer Abouhassan, Muhammad Rauf Ahsan, et al.
Diabetes, Obesity & Metabolism|May 15, 2020
Goal achievement of HbA1c and LDL-cholesterol in a randomized trial comparing colesevelam with ezetimibe: GOAL-RCTHarpreet S Bajaj, Ruth E Brown, Dishay Jiandani, et al.
Canadian Journal of Diabetes|June 25, 2022
Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA TrialHarpreet S Bajaj, Lisa Chu, Nandini Bansal, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Biochemistry|September 11, 2007
Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitusHui Wang, Qing H Meng, John R Gordon, et al.
Diabetes Research and Clinical Practice|August 26, 2019
Patient Reported Outcomes following initiation of Glucagon-like peptide-1 Receptor agonists in patients with type 2 Diabetes in a specialist endocrinology practice of the LMC diabetes registry: The PROGRESS-Diabetes studyRuth E Brown, Alexander Abitbol, Harpreet S Bajaj, et al.
Diabetes, Obesity & Metabolism|December 22, 2022
IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trialRonnie Aronson, Ruth E Brown, Lisa Chu, et al.
Diabetes Care|December 4, 2016
Lowest Glucose Variability and Hypoglycemia Are Observed With the Combination of a GLP-1 Receptor Agonist and Basal Insulin (VARIATION Study)Harpreet S Bajaj, Karri Venn, Chenglin Ye, et al.
Canadian Journal of Diabetes|May 29, 2018
Diabetes Canada Position Statement for People With Types 1 and 2 Diabetes Who Fast During RamadanHarpreet Singh Bajaj, Tyceer Abouhassan, Muhammad Rauf Ahsan, et al.
Diabetes, Obesity & Metabolism|May 15, 2020
Goal achievement of HbA1c and LDL-cholesterol in a randomized trial comparing colesevelam with ezetimibe: GOAL-RCTHarpreet S Bajaj, Ruth E Brown, Dishay Jiandani, et al.
Canadian Journal of Diabetes|June 25, 2022
Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA TrialHarpreet S Bajaj, Lisa Chu, Nandini Bansal, et al.
Pageof 1